Insulin aspart, recombinant Subcutaneous and Lodine XL
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lodine XL and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: etodolac
Brand name: Lodine, Lodine XL
Synonyms: Lodine XL (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lodosyn
- Insulin aspart, recombinant Subcutaneous-Lodrane 12 Hour
- Insulin aspart, recombinant Subcutaneous-Lodrane D
- Insulin aspart, recombinant Subcutaneous-Loestrin
- Insulin aspart, recombinant Subcutaneous-Loestrin 1.5/30
- Insulin aspart, recombinant Subcutaneous-Loestrin 1.5/30 Oral
- Lodine XL-Insulin degludec
- Lodine XL-Insulin Degludec (U-100) Prefilled Pens
- Lodine XL-Insulin Degludec (U-100) Vials
- Lodine XL-Insulin Degludec (U-200) Prefilled Pens
- Lodine XL-Insulin degludec and liraglutide
- Lodine XL-Insulin degludec and liraglutide Subcutaneous